The US companies with the highest ROI of the decade

Netflix, Nvidia and Lululemon

clock • 1 min read

Casey Paul, content executive at IG.com, analyses the best performing stocks over the past ten years across some of the world's most influential companies that feature in NASDAQ, DOW30 and the New York Stock Exchange.

Casey Paul, content executive at IG.com, analyses the best performing stocks over the past ten years across some of the world's most influential companies that feature in NASDAQ, DOW30 and the New York Stock Exchange.  The world is always looking for the next big company set to skyrocket into success, with the past decade seeing the likes of Uber and Netflix grow into some of the world's most profitable and renowned businesses on the planet.  But what were the companies that would have earned you the highest return on investment if you had invested in them ten years ago, and what will...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

While thematic funds offer diversification and a specialist knowledge base, investors must also consider the sensitivity to real bond yields inherent in these funds.

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
Deal volumes fell last year as rising interest rates brought the end of cheap money

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot